Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism Af… (NCT02924532) | Clinical Trial Compass
CompletedNot Applicable
Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total Thyroidectomy
300 participantsStarted 2012-02
Plain-language summary
The main objective of this study is to establish an optimal threshold Early parathormon (PTH) assay in order to exclude hypoparathyroidism , that is to say to obtain a negative predictive value of hypoparathyroidism highest possible.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients consecutively operated on between February 1, 2012 and December 1, 2013
* Total thyroidectomy +/- lymphadenectomy
* Respect of clinicobiological protocol presented above
* The ( the ) patient ( e) was informed ( e) on the implementation of the study 's objectives, constraints and patient rights
* The ( the ) patient ( e) is under ( e) at least 18 years
Exclusion Criteria:
* The ( the ) patient ( e) is under guardianship, curatorship or under guard saves justice
* It is not possible to give to ( the ) patient ( e) informed information
* History of cervical radiotherapy
* Previous history of dysfunction of the parathyroid glands
* Previous history of surgery of the parathyroid glands
* A history of kidney failure or hepatocellular
* History of osteomalacia or Paget's disease
* unhealed cancer antecedent
* History of sarcoidosis